Search Results

There are 2504 results for: content related to: Spironolactone Revisited

  1. You have free access to this content
    Aldosterone antagonists for preventing the progression of chronic kidney disease

    Intervention Review

    The Cochrane Library

    Davide Bolignano, Suetonia C Palmer, Sankar D Navaneethan and Giovanni FM Strippoli

    Published Online : 29 APR 2014, DOI: 10.1002/14651858.CD007004.pub3

  2. Spironolactone for hypertension

    Intervention Review

    The Cochrane Library

    Josh Batterink, Sarah N Stabler, Aaron M Tejani and Curt T Fowkes

    Published Online : 4 AUG 2010, DOI: 10.1002/14651858.CD008169.pub2

  3. You have free access to this content
    Interventions for hirsutism (excluding laser and photoepilation therapy alone)

    Intervention Review

    The Cochrane Library

    Esther J van Zuuren, Zbys Fedorowicz, Ben Carter and Nikolaos Pandis

    Published Online : 28 APR 2015, DOI: 10.1002/14651858.CD010334.pub2

  4. ENDOCRINE EFFECTS OF SPIRONOLACTONE IN MAN

    Clinical Endocrinology

    Volume 9, Issue 5, November 1978, Pages: 389–399, M. J. TIDD, C. E. HORTH, L. E. RAMSAY, J. R. SHELTON and R. F. PALMER

    Version of Record online : 17 MAR 2008, DOI: 10.1111/j.1365-2265.1978.tb03578.x

  5. SPIRONOLACTONE THERAPY IN HIRSUTISM AND ACNE

    Australasian Journal of Dermatology

    Volume 29, Issue 3, December 1988, Pages: 135–139, Annette W. Callan

    Version of Record online : 28 JUN 2007, DOI: 10.1111/j.1440-0960.1988.tb00385.x

  6. Targeting the aldosterone pathway in cardiovascular disease

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 1, February 2012, Pages: 135–145, Finn Gustafsson, Michel Azizi, Johann Bauersachs, Frederic Jaisser and Patrick Rossignol

    Version of Record online : 2 NOV 2011, DOI: 10.1111/j.1472-8206.2011.01004.x

  7. Medical Treatment of Ascites in Cirrhosis

    Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment, Second Edition

    Paolo Angeli, Angelo Gatta, Pages: 227–240, 2007

    Published Online : 25 OCT 2007, DOI: 10.1002/9780470987476.ch18

  8. INCREASED SERUM OESTRONE AND OESTRADIOL FOLLOWING SPIRONOLACTONE ADMINISTRATION IN HYPERTENSIVE MEN

    Clinical Endocrinology

    Volume 9, Issue 6, December 1978, Pages: 523–533, AKIHIKO MIYATAKE, KEIZO NOMA, KIYOHIDE NAKAO, YASUHIKO MORIMOTO and YUICHI YAMAMURA

    Version of Record online : 17 MAR 2008, DOI: 10.1111/j.1365-2265.1978.tb01510.x

  9. ANTIANDROGEN THERAPY IN DERMATOLOGY

    International Journal of Dermatology

    Volume 35, Issue 11, November 1996, Pages: 770–778, JAMES C. SHAW

    Version of Record online : 31 MAY 2007, DOI: 10.1111/j.1365-4362.1996.tb02970.x

  10. Water-soluble β-Cyclodextrins in Paediatric Oral Solutions of Spironolactone: Preclinical Evaluation of Spironolactone Bioavailability from Solutions of β-Cyclodextrin Derivatives in Rats

    Journal of Pharmacy and Pharmacology

    Volume 50, Issue 6, June 1998, Pages: 611–619, ANN M. KAUKONEN, HANS LENNERNÄS and JUKKA-PEKKA MANNERMAA

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1998.tb06894.x

  11. You have free access to this content
    Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure

    European Journal of Heart Failure

    Volume 16, Issue 2, February 2014, Pages: 143–150, Javaid Iqbal, Yasir Parviz, Bertram Pitt, John Newell-Price, Abdallah Al-Mohammad and Faiez Zannad

    Version of Record online : 14 DEC 2013, DOI: 10.1111/ejhf.31

  12. You have free access to this content
    Spironolactone dose-response relationships in healthy subjects.

    British Journal of Clinical Pharmacology

    Volume 13, Issue 4, April 1982, Pages: 513–518, GT McInnes, RM Perkins, JR Shelton and IR Harrison

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1982.tb01413.x

  13. You have full text access to this OnlineOpen article
    Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy

    Journal of Diabetes Investigation

    Volume 8, Issue 4, July 2017, Pages: 609–618, Li-Jing Sun, Yan-Ni Sun, Jian-Ping Shan and Geng-Ru Jiang

    Version of Record online : 1 MAR 2017, DOI: 10.1111/jdi.12629

  14. Aldosterone Antagonism in the Pharmacological Management of Chronic Heart Failure

    Heart Failure: Pharmacologic Management

    Arthur M. Feldman, Pages: 82–103, 2007

    Published Online : 16 NOV 2007, DOI: 10.1002/9780470994740.ch6

  15. You have free access to this content
    Spironolactone: An Old Friend Rediscovered

    The Journal of Clinical Hypertension

    Volume 8, Issue 7, July 2006, Pages: 467–469, Domenic A. Sica

    Version of Record online : 31 JAN 2007, DOI: 10.1111/j.1524-6175.2006.05155.x

  16. Hepatorenal syndrome and ascites - questions and answers

    Liver

    Volume 19, Issue s1, December 1999, Pages: 15–74, M. Bernardi, L. Blendis, A. K. Burroughs, G. Laffi, J. Rodes and P. Gentilini

    Version of Record online : 2 MAR 2007, DOI: 10.1111/j.1478-3231.1999.tb00092.x

  17. You have free access to this content
    Treatment Considerations With Aldosterone Receptor Antagonists

    The Journal of Clinical Hypertension

    Volume 13, Issue 1, January 2011, Pages: 65–69, Domenic A. Sica and John M. Flack

    Version of Record online : 4 OCT 2010, DOI: 10.1111/j.1751-7176.2010.00377.x

  18. The Effects of Four Months' Treatment with Spironolactone on Systemic Blood Pressure, Cardiac Output and Plasma Renin Activity in Hypertensive Patients

    Acta Medica Scandinavica

    Volume 202, Issue 1-6, January/December 1977, Pages: 373–377, Sture Bevegård, Jan Castenfors and Mats Danielson

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.0954-6820.1977.tb16846.x

  19. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne

    Intervention Review

    The Cochrane Library

    Julie Brown, Cindy Farquhar, Olivia Lee, Robyn Toomath and Ruth G Jepson

    Published Online : 15 APR 2009, DOI: 10.1002/14651858.CD000194.pub2

  20. You have free access to this content
    Comparison of single and divided daily dose spironolactone in the control of hypertension [letter]

    British Journal of Clinical Pharmacology

    Volume 12, Issue 4, October 1981, Pages: 585–588, GM Bell, L Fananapazir and JL Anderton

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1981.tb01271.x